Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep272 | Clinical case reports - Pituitary/Adrenal | ECE2016

Diagnostic challenges in severe primary hyperaldosteronism

Nijhoff Michiel , Appelman-Dijkstra Natasha , Pereira Alberto

Primary aldosteronism (PA) is generally caused by an adenoma or adrenal hyperplasia. To discern between these two, selective adrenal vein sampling (AVS) is necessary. Adequate interpretation requires that RAAS-interfering medication be withdrawn. We report a patient with severe PA, where it was not possible to safely withdraw RAAS-interfering medication.Case: A 37-year-old male was referred for AVS. He had documented PA and bilateral adrenal adenomas on ...

ea0041ep332 | Clinical case reports - Thyroid/Others | ECE2016

A novel clinical phenotype of acquired partial lipodystrophy associated with intensive childhood cytostatic treatment

Nijhoff Michiel , Corssmit Eleonora , Louwerens Marloes , Jazet Ingrid , Pereira Alberto

Context: Lipodystrophy is characterized by subcutaneous fat loss, fat maldistribution, and metabolic syndrome. We present a novel phenotype of partial acquired lipodystrophy, possibly associated with childhood chemotherapy.Case reports: Two adult female patients that had been exposed to intensive cytostatic treatment in childhood for leukemia and aplastic anemia, respectively, were referred for therapy resistant diabetes. Both patients had distinct parti...

ea0056gp113 | Diabetes Translational | ECE2018

Diazoxide pretreatment improves pancreatic islet survival in vitro and functionality in vivo

Nijhoff Michiel , Carlotti Francoise , Engelse Marten , de Koning Eelco

The efficacy of human islet transplantation is reduced by loss of islets directly after transplantation. Ischemia is likely to be an important contributing factor to the observed islet loss. Diazoxide inhibits insulin secretion by beta cells and has been shown to exhibit anti-apoptotic and anti-ischemic effects. We hypothesized that preincubation of human islets with diazoxide leads to improved islet survival and graft function.Methods: Isolated human pa...

ea0073oc6.3 | Oral Communications 6: Calcium and Bone | ECE2021

Bone material strength index is altered in patients with Cushing’s syndrome even after long-term remission

Schoeb Manuela , Sintenie Paula J.C. , Haalen Femke van , Nijhoff Michiel , de Vries Friso , Biermasz Nienke , Winter Elizabeth M. , Pereira Alberto M , Appelman-Dijkstra Natasha

BackgroundEndogenous Cushing’s syndrome (CS) is detrimental to bone. The skeletal complications are characterized by decreased bone formation and increased bone resorption, resulting in decreased bone mineral density (BMD) and an increased risk of fractures at time of diagnosis. After remission of the disease, BMD improves towards normal values but fracture rate remains elevated. Therefore, components of bone quality other than BMD, such as bone mat...